Heron Therapeutics’ combo drug for post-surgical pain wins FDA nod on third try
Heron Therapeutics’ combo drug for post-surgical pain wins FDA nod on third try
Heron Therapeutics is positioning its drug, Zynrelef, as a way to help patients avoid addictive opioid painkillers following surgery. The extended-release formulation offers analgesic effects over 72 hours when postsurgical pain is most severe and more likely to require pain management medication.
Shares0
The FDA has approved a Heron Therapeutics combination drug developed to treat postsurgical pain and help patients avoid the need for opioid painkillers, a regulatory decision that comes after the agency twice turned down applications from the biotech.
YFDAI Finance on Path to Push DeFi to the Limit, Starting with SafeSwap and Launchpad
YFDAI Finance, announces the launch of two new services – SafeSwap and
Launchpad, both key moves in the promotion of mass growth and adoption of DeFi services.
DeFi is becoming the “next big thing,” in which cryptocurrencies and their underlying blockchain technology deploy for new uses and a widening user-base. Among DeFi’s main selling points is the promise of better alternatives to what is offered in the traditional banking sector, in many cases at a fraction of the cost. Additional advantages include ultra-low barriers to otherwise excluded financial service clients and better investment opportunities with attractive returns in comparison to conventional instruments. All of these aspects of DeFi will exist in a context of enhanced transparency, security, and user control over their funds.
Poolz Reports 25x Oversubscription for $1M Private Sale theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.